Senthil Vel Sundaram

Filings by Senthil Vel Sundaram span 2 companies, the busiest being Nightstar Therapeutics plc and Terns Pharmaceuticals, Inc. Over a trading history stretching from 7 January 2019 to 31 May 2023, the count stands at 6 filings.

Both buying and selling appear: 3 purchases worth €13k, against 2 sales worth €13k. The net balance comes to €178 on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2023 alone, the filings show 2 purchases and no sales.

In size, the median ticket on the buying side is €2,783. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 2 June 2023, reports an open-market purchase of €2,783 in Terns Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.